PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 6715977

Ossicular reconstruction--a new prosthesis.

M V Kirtane·K S Parsram·A K Shah·P P Karnik
View original source ↗Export metadata ↓

Abstract

We have used human teeth for ossicular reconstruction in 20 tympanoplasties, the longest follow-up being over 2 years. The take of the graft and the hearing improvement have been very satisfactory and long-lasting. This preliminary report discusses the merits of the tooth as a prosthetic material for ossicular reconstruction. Our experience to-date indicates that the material satisfies all the criteria of an ideal prosthesis.

Explore related subjects

BioprosthesisCholesteatomaEar DiseasesEar OssiclesHumansIncusRupture, SpontaneousTissue PreservationTooth RootTympanoplastyComparative StudyJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M V Kirtane, K S Parsram, A K Shah, P P Karnik. 1984. Ossicular reconstruction--a new prosthesis.. https://doi.org/10.1017/s0022215100146882

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Early outcomes of tricuspid valve replacement in young children.

BACKGROUND: Early outcomes after tricuspid valve replacement in young children are ill defined. The experience of the Pediatric Cardiac Care Consortium (45 centers, 1984 to 2002) was reviewed to evaluate the results of tricuspid valve replacement in children <6 years of age. METHODS AND RESULTS: Ninety-seven patients who underwent initial tricuspid valve replacement are included in the present analysis. The most frequent cardiac diagnoses were Ebstein's anomaly (40%), pulmonary atresia (11%), and tetralogy of Fallot (8%). Age at tricuspid valve replacement was 2.9+/-1.7 years (mean+/-SD). Mean patient weight was 12.7+/-6.1 kg. The major outcome was survival to discharge. Associations among age, diagnosis, valve type/size, and outcome were evaluated through the use of chi2 analysis and logistic regression model fitting approaches. Hospital mortality was 26% and was very high (64%) in patients <1 year of age. A large size-to-weight ratio was the strongest predictor of mortality based on multivariable analysis (P<0.001). Mortality was 54% for patients with a size-to-weight ratio >2.5. Other complications included heart block requiring a pacemaker (13%) and thrombosis (5%). Pacemaker implantation was associated with the use of a mechanical valve (23% versus 6% bioprosthetic valve; P=0.01) CONCLUSIONS: Tricuspid valve replacement in young children is associated with high mortality, especially in infants <1 year of age. Surgical options other than tricuspid valve replacement such as transplantation may need to be considered in infants.

Bioprosthesis↗